Juvéderm Vollure™ XC New York City
JUVÉDERM VOLLURE™ XC is formulated with Allergan’s proprietary VYCROSS® technology, which blends different molecular weights of hyaluronic acid, contributing to the gel’s duration.4† Our first product featuring VYCROSS® technology, JUVÉDERM VOLUMA® XC, was FDAapproved to increase volume lost due to aging in the cheek area,5 followed by JUVÉDERM VOLBELLA® XC, FDA-approved for lip augmentation and correction of perioral rhytids.
Now with JUVÉDERM VOLLURE™ XC, the advanced VYCROSS® technology yields a custom engineered injectable gel product which was studied in the nasolabial folds, the number one dermal treatment area. It delivers a long-lasting result, up to 18 months*, that patients appreciate.
JUVÉDERM VOLLURE XC™ is specifically tailored with a balance of gel firmness and low cohesivity, yielding a versatile formulation that adds subtle volume for the correction of moderate to severe facial wrinkles and folds.
“What’s exciting about JUVÉDERM VOLLURE™ XC is that it was shown to last up to 18 months from the initial or touch-up injection in a majority of subjects, which is the longest lasting result shown in a clinical study in the nasolabial folds,”2 said Dr. Joely Kaufman, a board-certified dermatologist and clinical trial investigator. “As the number of patients seeking dermal filler treatments continues to grow, I am pleased that the technology created by Allergan has also followed that same trend, with a full range of products that will allow for tailoring of treatment based on specific patient needs.”
The most common side effects seen in the clinical study were temporary injection site responses at the treatment site such as swelling, tenderness, bruising, firmness lumps/bumps, redness, pain, discoloration, and itching. Most of these side effects resolved within 1 week.
Q: How does JUVÉDERM VOLLURE™ XC fit into the rest of the JUVÉDERM® Collection of Fillers?
A: The JUVÉDERM® Collection includes a spectrum of fillers specifically designed for different treatment areas and patient needs. JUVÉDERM VOLLURE™ XC brings VYCROSS® technology to the most requested dermal filler treatment area – nasolabial folds.
Q: JUVÉDERM VOLUMA® XC and JUVÉDERM VOLBELLA® XC are also formulated with VYCROSS® technology. How does JUVÉDERM VOLLURE™ XC compare?
A: JUVÉDERM VOLUMA® XC is specifically tailored to add volume and is indicated to correct age related volume loss in the cheek area. JUVÉDERM VOLBELLA® XC is designed to be a soft, smooth gel indicated for the lips and perioral area. JUVEDERM VOLLURE™ XC is tailored with a unique balance of gel properties to be firmer and more cohesive than JUVÉDERM VOLBELLA® XC, but less firm than JUVÉDERM VOLUMA® XC, making it appropriate for smoothing moderate to severe facial wrinkles and folds.
Q: It seems like JUVÉDERM VOLLURE™ XC is very similar to JUVÉDERM® Ultra Plus XC. What sets them apart?
A: JUVÉDERM® Ultra Plus XC and JUVÉDERM VOLLURE™ XC are both indicated for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds), however, they are uniquely formulated. JUVÉDERM® Ultra Plus XC is a more highly cross-linked, robust gel, while JUVÉDERM VOLLURE™ XC adds subtle, softer volume.
Q: Is JUVÉDERM VOLLURE™ XC a replacement for JUVÉDERM® Ultra Plus XC?
A: No, JUVÉDERM VOLLURE™ XC and JUVÉDERM® Ultra Plus XC are both indicated for moderate to severe facial wrinkles and folds, but their gel properties are different,1,4 so physicians now have an additional treatment option for patients. Your doctor will decide which product is most appropriate based on your specific needs and treatment goals.